Alishah, K., Birtel, M., Masoumi, E., Jafarzadeh, L., Mirzaee, H. R., Hadjati, J., . . . Asad, S. (2021). CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro. BMC.
Style de citation Chicago (17e éd.)Alishah, Khadijeh, Matthias Birtel, Elham Masoumi, Leila Jafarzadeh, Hamid Reza Mirzaee, Jamshid Hadjati, Ralf-Holger Voss, Mustafa Diken, et Sedighe Asad. CRISPR/Cas9-mediated TGFβRII Disruption Enhances Anti-tumor Efficacy of Human Chimeric Antigen Receptor T Cells in Vitro. BMC, 2021.
Style de citation MLA (8e éd.)Alishah, Khadijeh, et al. CRISPR/Cas9-mediated TGFβRII Disruption Enhances Anti-tumor Efficacy of Human Chimeric Antigen Receptor T Cells in Vitro. BMC, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.